We found that excessive ROS promoted chemotherapy resistance in NSCLC cells by upregulating the ABC transporter ABCG2 through a mechanism involving the canonical Nrf2 antioxidant pathway [36]. This evidence concerns the gene ABCG2 and non-small cell lung carcinoma.